Publication | Open Access
Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study
156
Citations
18
References
2018
Year
Autoimmune DiseaseOpen-label Extension StudyImmunologyGastroenterologyClinical GastroenterologyUlcerative ColitisMedicineDigestive System Diseases
| Year | Citations | |
|---|---|---|
Page 1
Page 1